title: Production of carbon monoxide by cytochrome P450 during iron-dependent lipid peroxidation.
abstract: Carbon monoxide (CO) formation was studied in the process of lipid peroxidation in phenobarbital-induced rabbit liver microsomes. The reaction was NADPH-dependent and required Fe(2+), which occurs in microsomes as being protein bound and is not a consequence of heme destruction. Zn-protoporphyrin IX, an inhibitor of the heme oxygenase activity, proved to have no effect on CO production, suggesting that heme oxygenase is not involved into the CO generation reaction. At the same time, the addition of cytochrome P450 typical inhibitors SKF 525A and metyrapone to the reaction mixture had an inhibitory effect on the CO formation rate. Antioxidants such as alpha-tocopherol and desferal inhibited lipid peroxidation in phenobarbital-induced rabbit liver microsomes, and in this case the CO production was not registered. Thus, on the basis of the results presented here it is possible to assert that the process of NADPH, Fe(2+)-dependent carbon monoxide formation in microsomes is a result of lipid peroxidation with cytochrome P450 2B4 participation.
authors.affiliation: Institute of Biomedical Chemistry RAMS, 119832, Pogodinskaya Street, 10, Moscow, Russia.
authors.forename: A I
authors.initials: AI
authors.lastname: Archakov
authors.forename: I I
authors.initials: II
authors.lastname: Karuzina
authors.forename: N A
authors.initials: NA
authors.lastname: Petushkova
authors.forename: A V
authors.initials: AV
authors.lastname: Lisitsa
authors.forename: V G
authors.initials: VG
authors.lastname: Zgoda
mesh_terms: D000818:Animals; D001189:Aryl Hydrocarbon Hydroxylases; D002248:Carbon Monoxide / Q000378:metabolism*; D003577:Cytochrome P-450 Enzyme System / Q000378:metabolism*; D003676:Deferoxamine / Q000494:pharmacology; D004790:Enzyme Induction; D004791:Enzyme Inhibitors / Q000494:pharmacology; D006419:Heme Oxygenase (Decyclizing) / Q000037:antagonists & inhibitors; D066298:In Vitro Techniques; D007501:Iron / Q000494:pharmacology; D015227:Lipid Peroxidation / Q000187:drug effects / Q000502:physiology*; D008797:Metyrapone / Q000494:pharmacology; D008862:Microsomes, Liver / Q000187:drug effects / Q000201:enzymology*; D010634:Phenobarbital / Q000494:pharmacology; D011335:Proadifen / Q000494:pharmacology; D011524:Protoporphyrins / Q000494:pharmacology; D011817:Rabbits; D013250:Steroid Hydroxylases / Q000378:metabolism*; D024502:alpha-Tocopherol / Q000494:pharmacology
chemical_list: D004791:Enzyme Inhibitors; D011524:Protoporphyrins; C017803:zinc protoporphyrin; D002248:Carbon Monoxide; D003577:Cytochrome P-450 Enzyme System; D011335:Proadifen; D007501:Iron; D013250:Steroid Hydroxylases; D001189:Aryl Hydrocarbon Hydroxylases; C050356:steroid 15-alpha-hydroxylase; D006419:Heme Oxygenase (Decyclizing); D024502:alpha-Tocopherol; D003676:Deferoxamine; D010634:Phenobarbital; D008797:Metyrapone